Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021

SELL
$1.67 - $2.95 $1.05 Million - $1.85 Million
-627,931 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$1.8 - $2.56 $272,192 - $387,118
151,218 Added 31.72%
627,931 $1.22 Million
Q3 2020

Nov 12, 2020

BUY
$2.04 - $3.74 $32,044 - $58,747
15,708 Added 3.41%
476,713 $1.14 Million
Q2 2020

Aug 04, 2020

BUY
$2.42 - $3.29 $1.12 Million - $1.52 Million
461,005 New
461,005 $1.35 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.27B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.